skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The role of somatostatin in 67 consecutive pancreatectomies: a randomized clinical trial

Original Research

(1401) Views  (357) Full article downloads

Authors: Anastasios Katsourakis, Louiza Oikonomou, Efthimios Chatzitheoklitos, et al

Published Date December 2010 Volume 2010:3 Pages 179 - 183
DOI: http://dx.doi.org/10.2147/CEG.S13984

Anastasios Katsourakis1, Louiza Oikonomou2, Efthimios Chatzitheoklitos1, George Noussios3, Michael Pitiakoudis4, Aleksandros Polychronidis4, Konstantinos Simopoulos4, Antonia Sioga2
1Surgical Department of "Agios Dimitrios" General Hospital, Thessaloniki, Greece; 2Department of Histology and Embryology, School of Medicine, "Aristotelian" University of Thessaloniki, Greece; 3Laboratory of Sports Medicine of Department of Physical Education (Serres), "Aristotelian" University of Thessaloniki, Greece; 4Department of Surgery, School of Medicine, "Democritian" University of Thrace, Greece

Background: Somatostatin has been found to be effective in the prevention of postoperative complications in pancreatic surgery. It can inhibit the pancreatic secretions that, quite often, are responsible for complications during the postoperative period.
Methods: We randomized 67 patients in 2 groups. In the study group (n = 35), somatostatin was administered 30 minutes prior to surgery as well as intraoperatively and postoperatively. No medication was given to the control group (n = 32). Biopsies were taken and processed for electron microscopy and ultrastructural morphometric analysis.
Results: Administration of somatostatin reduced the exocrine granule number, and the patients suffered from fewer postoperative complications.
Conclusions: Somatostatin reduces granule number and size of pancreatic cells, which can partially explain the prophylactic effect of the drug on early complications of pancreatic surgery, and which is confirmed by the clinical findings.

Keywords: electron microscopy, pancreatic resection, somatostatin, complication, histological findings






Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
ABO and rhesus blood group distribution in Kurds
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
Update on new approaches in the management of hepatocellular carcinoma
Amino acid-responsive Crohn's disease: a case study
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio